1. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). (December 2022) Authors: Argilés, Guillem; Mulet, Nuria; Valladares-Ayerbes, Manuel; Viéitez, José M.; Grávalos, Cristina; García-Alfonso, Pilar; Santos, Cristina; Tobeña, María; García-Paredes, Beatriz; Benavides, Manuel; Cano, María T.; Loupakis, Fotios; Rodríguez-Garrote, Mercedes; Rivera, Fernando; Goldberg, Richard ... Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗